ReviewPediatrics2008
Retinoblastoma: one world, one vision.
Review in Pediatrics, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07530458 (Retinoblastoma Consolidation), which is not on this map. Cited by 50 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Retinoblastoma Consolidation: A Retrospective Multivariate Analysis In Egyptian Population
Who cites it
50 citing papers in PubMed, 139 citations in OpenAlex.
- A Machine Learning Pipeline to Analyze Global Sentiment and Factors Influencing Retinoblastoma Treatment Hesitancy: Observational Infodemiology Study.Journal of medical Internet research · 2026Article
- Topotecan Microneedle Scleral Patch: A Transscleral Drug Delivery Study for Retinoblastoma.Ophthalmology science · 2026Article
- Cavitary retinoblastoma: Clinical features and treatment outcomes.Indian journal of ophthalmology · 2026Article
- Retinal organoid screening reveals ABT-737 and luminespib as potential agents against a cone- precursor-derived subtype of retinoblastoma.Molecular therapy. Oncology · 2026Article
- Retinoblastoma survival trend: a 30-year analysis from a referral single center in Iran.International journal of retina and vitreous · 2025Article
- Global, regional, and national burden of retinoblastoma in infants and young children: findings from the global burden of disease study 1990-2021.EClinicalMedicine · 2024Article
- Surgically Amenable Childhood Cancers: An Overview of the Burden and Challenges of Management in Low- and Middle-Income Countries.World journal of surgery · 2023Article
- Risk factors associated with abandonment of care in retinoblastoma: analysis of 692 patients from 10 countries.The British journal of ophthalmology · 2023Observational
- Review
- Survival trends for patients with retinoblastoma between 2000 and 2018: What has changed?Cancer medicine · 2023Article
- Telenursing implications for future education and practice: Nursing students' perspectives and knowledge from a course on child health.PloS one · 2023Article
- Impact of Laterality on Cumulative Survival in Patients Diagnosed with Retinoblastoma: A Retrospective Cohort Analysis of 1925 Cases in the Surveillance, Epidemiology, and End Results (SEER) Program.Clinical ophthalmology (Auckland, N.Z.) · 2021Article
- Epidemiological profile of retinoblastoma in North India: Implications for primary care and family physicians.Journal of family medicine and primary care · 2020Article
- Challenge of Retinoblastoma in Mexico in 2020: Perspectives and Solutions.Journal of ophthalmology · 2020Review
- Intra-Arterial Chemotherapy for Retinoblastoma: Four-Year Results from Tertiary Center in India.Ocular oncology and pathology · 2020Article
- Enabling Community Health Worker Recognition and Referral of Surgical Diseases: Pilot Study Results of a Pictorial Guide.World journal of surgery · 2019Article
- Delayed Enucleation With Neoadjuvant Chemotherapy in Advanced Intraocular Unilateral Retinoblastoma: AHOPCA II, a Prospective, Multi-Institutional Protocol in Central America.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2019Article
- Retinoblastoma in Asia.Eye (London, England) · 2019Review
- Head and Eye Trauma Before Retinoblastoma Diagnosis.Cancer management and research · 2019Article
- Retinoblastoma in Sub-Saharan Africa: Case Studies of the Republic of Côte d'Ivoire and the Democratic Republic of the Congo.Journal of global oncology · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors at 14 institutions in 8 countries.
Funding
Abstract
Retinoblastoma is curable when diagnosed early and treated appropriately; however, the prognosis is dismal when the basic elements of diagnosis and treatment are lacking. In developing countries, poor education, lower socioeconomic conditions, and inefficient health care systems result in delayed diagnosis and suboptimal care. Furthermore, the complexity of multidisciplinary care required is seldom possible. Whereas ocular salvage is a priority in the Western world, death from retinoblastoma is still a major problem in developing countries. To bring the 2 ends of this spectrum together and provide a forum for discussion, the "One World, One Vision" symposium was organized, at which clinicians and researchers from various cultural, geographic, and socioeconomic backgrounds converged to discuss their experiences. Strategies for early diagnosis in developing countries were discussed. Elements of the development of retinoblastoma centers in developing countries were discussed, and examples of successful programs were highlighted. An important component in this process is twinning between centers in developing countries and mentor institutions in high-income countries. Global initiatives by nongovernmental organizations such as the International Network for Cancer Treatment and Research, Orbis International, and the International Agency for Prevention of Blindness were presented. Treatment of retinoblastoma in developing countries remains a challenge; however, it is possible to coordinate efforts at multiple levels, including public administrations and nonprofit organizations, to improve the diagnosis and treatment of retinoblastoma and to improve the outcome for these children.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.